The pediatric cardiology pharmacopeia: 2013 update

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Critical Care Medicine

Background:

• Medications are vital for managing pediatric heart diseases, especially those with increased pulmonary blood flow.
• Anticongestive heart failure medications are often required long-term before surgical or interventional procedures.
• Pharmacologic support is critical during the postoperative period for pediatric cardiac patients.

Purpose of the Study:

• To provide an updated medication guide for healthcare practitioners caring for children with heart diseases.
• To highlight the role of anticongestive heart failure medications and inotropic agents.
• To emphasize the importance of pharmacologic management in advanced pediatric cardiac care.

Main Methods:

• Review of current literature on pediatric cardiovascular pharmacotherapy.
• Synthesis of information on medications used for heart failure and postoperative care.
• Focus on agents commonly used in pediatric cardiac intensive care units.

Main Results:

• Identification of key medication classes for pediatric heart failure management.
• Emphasis on the increased need for inotropic agents and diuretics postoperatively.
• Highlighting the role of advanced pharmacologic agents in improving outcomes for young surgical patients.

Conclusions:

• A comprehensive understanding of cardiac medications is essential for optimal pediatric patient outcomes.
• Pharmacologic management is a cornerstone of care, complementing surgical and interventional strategies.
• This guide serves as a resource for evidence-based medication use in pediatric cardiology.